Skip to main content

Table 5 AS and DHA recovery after 3 months in accelerated aging conditions (40°C/75%RH)

From: The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

 

AS content (%)

DHA content (%)

Arsumax®

> 95

3.3

Monolayer ASAQ tablet

97.8

3.4

Bilayer ASAQ tablet

99.1

< LOQ

  1. Comparison between monolayer tablets with pH regulator (batch n° 30411), bilayer high dosage tablets (batch n° 40166) and commercially available reference of AS tablets, Arsumax®
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us